Therma Bright Inc. has made notable progress in the compression therapy sector with its Venowave VW5 device, a portable, battery-powered solution designed to meet the healthcare needs of an aging population. The device's quick Medicare and Medicaid reimbursement approvals, including a HCPCS Level II code secured within 60 days, underscore its potential impact. Since October 1, 2024, more than 110 units have been deployed across the U.S., with 25 already fully reimbursed through commercial and federal healthcare networks.
The Venowave VW5 distinguishes itself in the medical device market through its compact design and efficacy. Weighing only 250 grams, it enhances vascular and lymphatic flow in lower limbs, with clinical studies reporting a 64% increase in venous blood flow within two minutes and an 88% increase after 50 minutes of use. These features make it a valuable tool for non-invasive treatment.
Strategic collaborations are key to Therma Bright's expansion. A Letter of Intent with DME Authority promises $6 million in Venowave VW5 purchases in the first half of 2025, while Valor Medical Solutions has ordered 100 units, with plans to increase orders biweekly. These partnerships reflect confidence in the device's market potential.
The global compression therapy market, expected to grow from $4.18 billion in 2024 to $6.72 billion by 2033, offers substantial opportunities for Therma Bright. The Venowave VW5's unique position as the only Medicare-approved mobile mechanical compression system under HCPCS code E0683, eligible for reimbursement across ten medical indications, enhances its appeal. Its FDA classification as Durable Medical Equipment and suitability for multiple patients further solidify its market position.
Rob Fia, CEO of Therma Bright, highlights the company's growth prospects, citing rapid reimbursement processing and rising patient demand as drivers for revenue increases in 2025 and beyond. As the healthcare landscape evolves, Therma Bright's innovative approach to compression therapy with the Venowave VW5 represents a significant advancement in medical technology, offering promising benefits for patients and healthcare providers alike.
